Lansforsakringar Fondforvaltning Ab (Publ) Legend Biotech Corp Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $8.19 Billion
- Q4 2024
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Legend Biotech Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 28,093 shares of LEGN stock, worth $938,306. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,093Holding current value
$938,306% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
85.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$251 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$227 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$200 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$191 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$191 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.59B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...